Ventricular Arrhythmias in Left Ventricular Assist Device Patients-Current Diagnostic and Therapeutic Considerations.
Laura ZałuckaEwa ŚwierżyńskaMichał OrczykowskiKrzysztof DutkowskiJarosław SzymańskiJarosław KuriataRafał DąbrowskiPiotr KołsutŁukasz SzumowskiMaciej SterlińskiPublished in: Sensors (Basel, Switzerland) (2024)
Left ventricular assist devices (LVAD) are used in the treatment of advanced left ventricular heart failure. LVAD can serve as a bridge to orthotopic heart transplantation or as a destination therapy in cases where orthotopic heart transplantation is contraindicated. Ventricular arrhythmias are frequently observed in patients with LVAD. This problem is further compounded as a result of diagnostic difficulties arising from presently available electrocardiographic methods. Due to artifacts from LVAD-generated electromagnetic fields, it can be challenging to assess the origin of arrhythmias in standard ECG tracings. In this article, we will review and discuss common mechanisms, diagnostics methods, and therapeutic strategies for ventricular arrhythmia treatment, as well as numerous problems we face in LVAD implant patients.
Keyphrases
- left ventricular
- heart failure
- left ventricular assist device
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- hypertrophic cardiomyopathy
- cardiac resynchronization therapy
- aortic stenosis
- peritoneal dialysis
- acute myocardial infarction
- prognostic factors
- catheter ablation
- left atrial
- stem cells
- atrial fibrillation
- bone marrow
- coronary artery disease
- high frequency
- aortic valve
- mesenchymal stem cells
- replacement therapy
- transcatheter aortic valve replacement
- smoking cessation
- cell therapy
- chemotherapy induced